Panel Perspectives on Real-World Challenges in AL Amyloidosis

What Would You Do? CME/CNE/CPE

Conrad New York Downtown
Friday, January 9, 2026 | 6:30 PM - 8:00 PM TZ
event presence logo
Supported by independent educational grants from Alexion Pharmaceuticals, Inc. and Johnson & Johnson.

overview

This 90-minute symposium will feature a panel of experts who will review the intricacies of care associated with the management of light chain (AL) amyloidosis. They will provide expert guidance and real-world perspectives related to treatment selection, practical challenges, and emerging approaches. Attendees will be able to engage directly with the expert panel in an interactive Q&A session.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

AGENDA

6:00 PM TZ

6:30 PM TZ

6:35 PM TZ

6:55 PM TZ

7:25 PM TZ

7:50 PM TZ

backstage pass
Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video encouraged*

LOCATION

Conrad New York Downtown

102 North End Ave, New York, New York, 10282

West Ballroom

TARGET AUDIENCE

This educational activity is intended for an audience of hematologists/oncologists, primary care physicians, cardiologists, and other members of the care team, designed to improve outcomes for people with systemic light chain (AL) amyloidosis in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to integrate evidence-based insights into the personalized diagnosis and management of AL amyloidosis.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have increased knowledge regarding the[/para] [list][item]Evidence-based approaches to caring for patients with AL amyloidosis [/list] [para]Have greater competence related to[/para] [list][item]Key clinical and laboratory findings for the diagnosis of AL amyloidosis [item]Treatment strategies for patients with AL amyloidosis [/list] [para]Demonstrate greater confidence in their ability to[/para] [list][item]Apply insights from real-world cases to improve patient outcomes in AL amyloidosis clinical practice[/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
accreditation logo
medscape logo
[title]For Physicians[/title] [text]Medscape, LLC designates this live activity for a maximum of 1.50 [bold][italic]AMA PRA Category 1 Credit(s)[/italic][super]TM[/super][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[/text] [break] [title]For Nurses[/title] [text]Awarded up to 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs.[/text] [break] [title]For Pharmacists[/title] [text]Medscape designates this continuing education activity for ​1.50​ contact hour(s) (​0.150​ CEUs) (Universal Activity Number: ​JA0007105-0000-26-009-L01-P). Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.[/text]
© 2025 MedscapeLIVE! All Rights Reserved | Medscape Education Terms of Service | Privacy Policy